Free Trial

Q2 Earnings Estimate for Jushi Issued By Atb Cap Markets

Jushi logo with Medical background

Jushi Holdings Inc. (OTCMKTS:JUSHF - Free Report) - Equities research analysts at Atb Cap Markets decreased their Q2 2025 earnings per share (EPS) estimates for shares of Jushi in a note issued to investors on Sunday, May 11th. Atb Cap Markets analyst F. Gomes now anticipates that the company will post earnings per share of ($0.07) for the quarter, down from their previous forecast of ($0.06). The consensus estimate for Jushi's current full-year earnings is ($0.23) per share. Atb Cap Markets also issued estimates for Jushi's Q4 2025 earnings at ($0.06) EPS and FY2025 earnings at ($0.27) EPS.

Jushi (OTCMKTS:JUSHF - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.03). The firm had revenue of $63.85 million during the quarter, compared to analysts' expectations of $66.23 million.

Jushi Trading Up 0.1%

JUSHF stock opened at $0.35 on Wednesday. The stock has a 50-day moving average price of $0.31 and a 200-day moving average price of $0.33. Jushi has a 1-year low of $0.22 and a 1-year high of $0.78. The firm has a market cap of $69.61 million, a PE ratio of -1.31 and a beta of -0.86.

Jushi Company Profile

(Get Free Report)

Jushi Holdings Inc, a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands.

See Also

Earnings History and Estimates for Jushi (OTCMKTS:JUSHF)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Jushi Right Now?

Before you consider Jushi, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jushi wasn't on the list.

While Jushi currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

7 Nuclear Stocks One Announcement Away from Exploding
3 AI ETFs for Steady Gains in 2025 (Without the Wild Volatility)
Goldman Sachs Warns of 20% Market Drop—Are They Right?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines